Skip to content

Orange Book Blog

At the intersection of Patent and FDA Law

About
Authors
Disclaimer

Recent Posts

A note on ANDA settlement agreements
Hikma v. Vanda: Oral Argument Recap
Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
Should ANDA filers be using the PTAB to mount early challenges to OB patents?
Switching to WordPress

Twitter
Facebook
Instagram

About

Welcome to the Orange Book Blog! We’re a group of patent attorneys who like to write about ongoing events in the world of Hatch-Waxman Litigation, as well as biosimilars and related topics.

Blog at WordPress.com.

Subscribe Subscribed
- Orange Book Blog
- Already have a WordPress.com account? Log in now.